Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Targan

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune systemK A Papadakis, J Prehn, V Nelson, et al.
The American Journal of Gastroenterology|July 27, 2001
Outcome of cytomegalovirus infections in patients with inflammatory bowel diseaseK A Papadakis, J K Tung, S W Binder, et al.
Gastroenterology|August 1, 1992
Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneityF Shanahan, R H Duerr, J I Rotter, et al.
Inflammatory Bowel Diseases|August 23, 2001
An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapyM C Dubinsky, P V Hassard, E G Seidman, et al.
Human Immunology|February 26, 2000
HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populationsE A Trachtenberg, H Yang, E Hayes, et al.
Gut|October 16, 2001
High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosisP R Fleshner, E A Vasiliauskas, L Y Kam, et al.
Inflammatory Bowel Diseases|June 1, 2001
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot studyB E Sands, W J Tremaine, W J Sandborn, et al.
Gut|August 6, 1998
Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic roleJ F Quinton, B Sendid, D Reumaux, et al.
Gastroenterology|December 2, 1999
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's diseaseE A Vasiliauskas, L Y Kam, M T Abreu-Martin, et al.
The American Journal of Gastroenterology|December 1, 1995
Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosisB J Zins, W J Sandborn, C R Penna, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune systemK A Papadakis, J Prehn, V Nelson, et al.
The American Journal of Gastroenterology|July 27, 2001
Outcome of cytomegalovirus infections in patients with inflammatory bowel diseaseK A Papadakis, J K Tung, S W Binder, et al.
Gastroenterology|August 1, 1992
Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneityF Shanahan, R H Duerr, J I Rotter, et al.
Inflammatory Bowel Diseases|August 23, 2001
An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapyM C Dubinsky, P V Hassard, E G Seidman, et al.
Human Immunology|February 26, 2000
HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populationsE A Trachtenberg, H Yang, E Hayes, et al.
Gut|October 16, 2001
High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosisP R Fleshner, E A Vasiliauskas, L Y Kam, et al.
Inflammatory Bowel Diseases|June 1, 2001
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot studyB E Sands, W J Tremaine, W J Sandborn, et al.
Gut|August 6, 1998
Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic roleJ F Quinton, B Sendid, D Reumaux, et al.
Gastroenterology|December 2, 1999
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's diseaseE A Vasiliauskas, L Y Kam, M T Abreu-Martin, et al.
The American Journal of Gastroenterology|December 1, 1995
Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosisB J Zins, W J Sandborn, C R Penna, et al.
Pageof 12